Fabio Nascimbeni

Epidemiology · 2016–2020

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Fabio Nascimbeni trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Targher

Who trusts Fabio Nascimbeni overall

  1. G. Targher

Papers from Fabio Nascimbeni's perspective

Ordered by how strongly the researchers Fabio Nascimbeni trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (Nature Reviews Gastroenterology &Hepatology)
  2. Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
  3. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis (Journal of Gastroenterology and Hepatology)
  4. Association between Non-invasive Fibrosis Markers and Mortality among Adults with Non-alcoholic Fatty Liver Disease in the United States (Hepatology)
  5. Inflammation, metaflammation and immunometabolic disorders (Nature)
  6. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis (Hepatology)
  7. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes (Hepatology)
  8. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. (Journal of Clinical Investigation)
  9. The Plasma Lipidomic Signature of Nonalcoholic Steatohepatitis (Hepatology)
  10. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. (Cell Metabolism)

Their papers